Confidence in Navigating Challenges to Biomarker Development & CDx Milestones
Time: 11:40 am
day: Day One
Details:
- How established, approved testing platforms can expand your biomarker population and accelerate timelines to CDx approval
- Learn how to validate innovative new biomarkers, such as HRDsig, MTAP loss, and detection of clonal hematopoiesis (CH) for inclusion in your clinical trials
- Review emerging CDx opportunities RNA, heme malignancies, and real-world data
